Torqur taps Lonza to power late-stage push for skin cancer therapy
Lonza will take on technology transfer, process optimization, and cGMP manufacturing, leveraging its global network and expertise in highly potent compounds
Lonza will take on technology transfer, process optimization, and cGMP manufacturing, leveraging its global network and expertise in highly potent compounds
She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The investigational new drug application with FDA was actually for NEOK002, an EGFR/MUC1-targeting antibody-drug conjugate aimed at solid tumors
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
The inspection is now closed, and no regulatory action has been recommended
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
Beyond clinical trials, real-world evidence is adding weight to AbbVie’s claims
The programme aims to provide critical healthcare services to approximately 4 lakh people in remote and resource-scarce communities
Subscribe To Our Newsletter & Stay Updated